Injury trends aboard US Navy vessels: A 50-year analysis of mishaps at sea.

Autor: Benham DA; From the Department of Surgery (D.A.B., M.C.V., M.D.T.), Navy Medicine Readiness and Training Command (NMRTC), San Diego, California; Fleet Surgical Team Seven (D.A.B.), Okinawa, Japan; Virtual Medical Center (J.K.), NMRTC, San Diego, California, 3rd Medical Battalion (K.D.C.), 3rd Marine Logistics Group, Camp Foster, Okinawa, Japan; NMRTC (R.M.), Portsmouth, Virginia; and 1st Medical Battalion (T.D.E., M.D.T.), 1st Marine Logistics Group, Camp Pendleton, California., Vasquez MC, Kerns J, Checchi KD, Mullinax R, Edson TD, Tadlock MD

Publikováno v: The journal of trauma and acute care surgery [J Trauma Acute Care Surg] 2023 Aug 01; Vol. 95 (2S Suppl 1), pp. S41-S49. Date of Electronic Publication: 2023 May 18.

Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas.

Autor: Wang, Yin¹ (AUTHOR), Hu, Wenxuan² (AUTHOR), Zhou, Boya³ (AUTHOR), Zhao, Yu⁴ (AUTHOR), Tang, Yufei⁴ (AUTHOR), Deng, Zhiyong¹ (AUTHOR) yichun1988@yeah.net, Chen, Minbin^1,5 (AUTHOR) mbinchen@163.com

Publikováno v: Cancer Cell International. 12/24/2024, Vol. 24 Issue 1, p1-16. 16p.

Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.

Autor: Duan, Hao¹ (AUTHOR), Ren, Jianlan² (AUTHOR), Wei, Shiyou³ (AUTHOR), Yang, Zhenyu³ (AUTHOR), Li, Chuan³ (AUTHOR), Wang, Zhenning⁴ (AUTHOR), Li, Meichen⁵ (AUTHOR), Wei, Zhi² (AUTHOR) zhiwei@njit.edu, Liu, Yu⁶ (AUTHOR), Wang, Xiuqi⁶ (AUTHOR), Lan, Hongbin⁶ (AUTHOR), Zeng, Zhen³ (AUTHOR), Xie, Maodi⁷ (AUTHOR), Xie, Yuan¹ (AUTHOR), Wu, Suwen⁸ (AUTHOR), Hu, Wanming⁹ (AUTHOR), Guo, Chengcheng¹ (AUTHOR), Zhang, Xiangheng¹ (AUTHOR), Liang, Lun¹⁰ (AUTHOR), Yu, Chengwei¹¹ (AUTHOR)

Publikováno v: Genome Medicine. 11/26/2024, Vol. 16 Issue 1, p1-30. 30p.

An inhibitor of oxidative phosphorylation exploits cancer vulnerability.

Autor: Molina JR; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun Y; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Protopopova M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gera S; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bandi M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bristow C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., McAfoos T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morlacchi P; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Agilent Technologies Inc., Lexington, MA, USA., Ackroyd J; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA., Agip AA; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK., Al-Atrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Asara J; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Bardenhagen J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carrillo CC; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carroll C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chang E; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ciurea S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cross JB; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Czako B; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Deem A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., de Groot JF; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dong JW; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Feng N; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gao G; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gay J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Do MG; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Greer J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Giuliani V; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Han L; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Henry VK; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hirst J; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK., Huang S; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang Y; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kang Z; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khor T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konoplev S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin YH; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA., Liu G; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lodi A; Department of Nutritional Sciences, University of Texas at Austin, Austin, TX, USA., Lofton T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahendra M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Matre P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mullinax R; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Peoples M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petrocchi A; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rodriguez-Canale J; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Serreli R; Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Wellcome Trust/MRC Building, Cambridge Biomedical Campus, Cambridge, UK., Shi T; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Smith M; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tabe Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Next Generation Hematology Laboratory Medicine, Department of Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan., Theroff J; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tiziani S; Department of Nutritional Sciences, University of Texas at Austin, Austin, TX, USA., Xu Q; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang Q; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Muller F; Department of Cancer Imaging Systems, University of Texas MD Cancer Center, Houston, TX, USA., DePinho RA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Toniatti C; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Draetta GF; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heffernan TP; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jones P; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Di Francesco ME; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Marszalek JR; Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrmarszalek@mdanderson.org.

Publikováno v: Nature medicine [Nat Med] 2018 Jul; Vol. 24 (7), pp. 1036-1046. Date of Electronic Publication: 2018 Jun 11.

A Rapid Combinatorial Approach to Assembling Synthetic Prokaryotic and Eukaryotic Protein Expression Vectors.

Autor: Mullinax R; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA. becky.mullinax@agilent.com., Johns SE; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., Rhodes D; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., Zhang V; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., McKinney N; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., Felts KA; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., Carstens CP; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA., Sheffield P; Genomics R&D, Agilent Technologies Inc., La Jolla, CA, USA.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2018; Vol. 1772, pp. 457-468.